These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29330546)

  • 21. Descriptive epidemiology of Down's syndrome in Estonia.
    Reimand T; Ounap K; Zordania R; Ilus T; Uibo O; Sitska M; Talvik T
    Paediatr Perinat Epidemiol; 2006 Nov; 20(6):512-9. PubMed ID: 17052289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Natural History of Trisomy 21: Outcome Data from a Large Tertiary Referral Centre.
    O'Connor C; Moore R; McParland P; Hughes H; Cathcart B; Higgins S; Mahony R; Carroll S; Walsh J; McAuliffe F
    Fetal Diagn Ther; 2021; 48(8):575-581. PubMed ID: 34583352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis.
    Wortelboer MJ; De Wolf BT; Verschuuren-Bemelmans CC; Reefhuis J; Mantingh A; Beekhuis JR; Cornel MC
    Prenat Diagn; 2000 Sep; 20(9):709-13. PubMed ID: 11015698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
    de Vigan C; Khoshnood B; Cadio E; Vodovar V; Goffinet F
    Gynecol Obstet Fertil; 2008 Feb; 36(2):146-150. PubMed ID: 18249576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France].
    Dupont JM; Simon-Bouy B; Zebina A; Pessione F; Royère D; Doco-Fenzy M;
    Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):152-157. PubMed ID: 28258854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based study of prevalence of Down syndrome in Southern Thailand.
    Jaruratanasirikul S; Kor-Anantakul O; Chowvichian M; Limpitikul W; Dissaneevate P; Intharasangkanawin N; Sattapanyo A; Pathompanitrat S; Sriplung H
    World J Pediatr; 2017 Feb; 13(1):63-69. PubMed ID: 27878784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in the Lothian region of Scotland, 1978-1992.
    Huether CA; Haroldson K; Ellis PM; Ramsay CN
    Genet Epidemiol; 1996; 13(4):367-75. PubMed ID: 8894639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of maternal age distribution on the expected live birth prevalence of Down's syndrome in the metropolitan France between 1965 and 2008].
    Rousseau T; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):284-9. PubMed ID: 20381272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing.
    Verweij EJ; Jacobsson B; van Scheltema PA; de Boer MA; Hoffer MJ; Hollemon D; Westgren M; Song K; Oepkes D
    Prenat Diagn; 2013 Oct; 33(10):996-1001. PubMed ID: 23794121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between timing of diagnosis of trisomy 21, 18, and 13 and maternal socio-economic status in Victoria, Australia: A population-based cohort study from 2015 to 2016.
    Kluckow E; Halliday J; Poulton A; Lindquist A; Hutchinson B; Bethune M; Bonacquisto L; Da Silva Costa F; Gugasyan L; Harraway J; Howden A; Kulkarni A; Martin N; McCoy R; Menezes M; Nisbet D; Palma-Dias R; Pertile MD; Poulakis Z; Hui L
    Prenat Diagn; 2019 Dec; 39(13):1254-1261. PubMed ID: 31691307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more.
    Ghi T; Arcangeli T; Ravennati F; Salsi G; Montaguti E; Pacella G; Maroni E; Pittalis MC; Pompilii E; Pilu G; Rizzo N
    J Matern Fetal Neonatal Med; 2015 Apr; 28(6):674-8. PubMed ID: 24866349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013.
    Maxwell S; Bower C; O'Leary P
    Prenat Diagn; 2015 Dec; 35(13):1324-30. PubMed ID: 26411476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
    Witters I; Fryns JP
    Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.
    Neyt M; Hulstaert F; Gyselaers W
    BMJ Open; 2014 Nov; 4(11):e005922. PubMed ID: 25380810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
    Iliyasu Z; Gilmour WH; Stone DH
    Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
    Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
    Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends in the prevalence of Down syndrome in Japan, 1980-1997.
    Hoshi N; Hattori R; Hanatani K; Okuyama K; Yamada H; Kishida T; Yamada T; Sagawa T; Sumiyoshi Y; Fujimoto S
    Am J Med Genet; 1999 Jun; 84(4):340-5. PubMed ID: 10340648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach of digital PCR system for non-invasive prenatal screening of trisomy 21.
    Lee SY; Kim SJ; Han SH; Park JS; Choi HJ; Ahn JJ; Oh MJ; Shim SH; Cha DH; Hwang SY
    Clin Chim Acta; 2018 Jan; 476():75-80. PubMed ID: 29170101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal Age-Specific Rates for Trisomy 21 and Common Autosomal Trisomies in Fetuses from a Single Diagnostic Center in Thailand.
    Jaruthamsophon K; Sriplung H; Charalsawadi C; Limprasert P
    PLoS One; 2016; 11(11):e0165859. PubMed ID: 27812158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are there any changes in Down Syndrome prevalence in France following the implementation of the measurement of nuchal translucency and maternal serum screening?].
    Goujard J
    Gynecol Obstet Fertil; 2004 Jun; 32(6):496-501. PubMed ID: 15217564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.